- Home
- AGS vs CSTL Comparison
AGS vs CSTL Comparison
Compare AGS & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGS
- CSTL
- Stock Information
- Founded
- AGS 2005
- CSTL 2007
- Country
- AGS United States
- CSTL United States
- Employees
- AGS N/A
- CSTL N/A
- Industry
- AGS Miscellaneous manufacturing industries
- CSTL Medical Specialities
- Sector
- AGS Consumer Discretionary
- CSTL Health Care
- Exchange
- AGS Nasdaq
- CSTL Nasdaq
- Market Cap
- AGS 508.0M
- CSTL 456.2M
- IPO Year
- AGS 2018
- CSTL 2019
- Fundamental
- Price
- AGS $12.44
- CSTL $20.35
- Analyst Decision
- AGS Hold
- CSTL Strong Buy
- Analyst Count
- AGS 1
- CSTL 6
- Target Price
- AGS $12.50
- CSTL $37.67
- AVG Volume (30 Days)
- AGS 377.4K
- CSTL 402.3K
- Earning Date
- AGS 08-06-2025
- CSTL 08-04-2025
- Dividend Yield
- AGS N/A
- CSTL N/A
- EPS Growth
- AGS 852.53
- CSTL N/A
- EPS
- AGS 1.16
- CSTL N/A
- Revenue
- AGS $393,717,000.00
- CSTL $347,083,000.00
- Revenue This Year
- AGS $4.30
- CSTL N/A
- Revenue Next Year
- AGS $5.14
- CSTL $1.36
- P/E Ratio
- AGS $10.79
- CSTL N/A
- Revenue Growth
- AGS 6.60
- CSTL 38.43
- 52 Week Low
- AGS $11.09
- CSTL $15.45
- 52 Week High
- AGS $12.51
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- AGS 74.90
- CSTL 69.63
- Support Level
- AGS $12.36
- CSTL $18.18
- Resistance Level
- AGS $12.41
- CSTL $19.18
- Average True Range (ATR)
- AGS 0.03
- CSTL 0.84
- MACD
- AGS -0.00
- CSTL 0.24
- Stochastic Oscillator
- AGS 82.61
- CSTL 93.60
About AGS PlayAGS Inc.
PlayAGS Inc is a designer and supplier of gaming products and services for the gaming industry. The company mainly supplies electronic gaming machines (EGM), server-based systems and back-office systems which are used by casinos, and various gaming locations. Its operating segments are EGM, Table Products, and Interactive. The EGM segment offers a selection of video slot titles developed for the world-wide marketplace as well as EGM cabinets. Its Table Products segments include live proprietary table games and side bets, as well as ancillary table products. The Interactive segment consists of delivering games through mobile apps such as Lucky Play Casino and Vegas Fever. It earns a majority of its revenue from Electronic Gaming Machines segment and geographically from the United States.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.